RNL Replay: Lupus

Be sure to sign up for this week's TNR: Mastering SLE on Tuesday April 30th at 6:30pm EST. 

What percentage of lupus patients experience a flare each year?

Lupus flares are primarily triggered by the activation of the adaptive immune system.

Type I interferons (IFNs) play a significant role in lupus flares and can be targeted by treatments like anifrolumab.

Belimumab use in lupus works quickly because it deals with antibody-secreting cells.

In SLE, proteinuria is a reliable indicator that correlates well with lupus nephritis activity.

Repeat kidney biopsies in lupus nephritis patients often lead to a change in treatment.

The 2023 EULAR recommendations for management of systemic lupus erythematosus (SLE) suggest that hydroxychloroquine (HCQ) is recommended for all patients with lupus.

In lupus: urinary levels of IL-16 and CD163 have been confirmed to be the urinary biomarkers that most correlated with histological activity on renal biopsy.

Select one:

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright {{ 'now'|date('Y') }} All Rights Reserved.